Compare LTC Properties Inc (LTC) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LTC Properties Inc vs Natera Inc. Common Stock — how do they compare? LTC Properties Inc trades at $42.66 (market cap $2.31B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 24.7× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.31% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold LTC Properties Inc for 89 Days and Natera Inc. Common Stock for 0 Days on average.
| LTC | NTRA | |
|---|---|---|
Market Cap | $2.31B | $57.03B |
Volume | 323,404 | 1,131,157 |
Sector | Real Estate | Health |
52-Week High | $43.50 | $425.64 |
52-Week Low | $34.04 | $179.42 |
Typical Hold Time | 89 Days | 0 Days |
Enterprise Value | $3.05B | $56.18B |
Dividend Yield | 5.31% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LTC Properties trades at $43.20, up 0.35% with a bullish technical signal and strong fundamental metrics including 38.93% net income margin and 12.11% ROE. Recent acquisitions totaling $360 million accelerate the SHOP portfolio transition, while consistent monthly dividends of $0.19 provide income stability. Revenue growth continues with 2025 revenue reaching $263 million, though profit margins have moderated from historical highs.
The outlook remains positive with analyst consensus target of $49.67 representing 15% upside potential. Key risks include rising interest rates impacting REIT valuations and execution challenges in portfolio transformation. The stock offers balanced risk-reward with income generation and growth potential from strategic acquisitions in the seniors housing sector.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
